Abstract

BackgroundAlthough methicillin-susceptible Staphylococcus aureus (MSSA) native bone and joint infection (BJI) constitutes the more frequent clinical entity of BJI, prognostic studies mostly focused on methicillin-resistant S. aureus prosthetic joint infection. We aimed to assess the determinants of native MSSA BJI outcomes.MethodsRetrospective cohort study (2001–2011) of patients admitted in a reference hospital centre for native MSSA BJI. Treatment failure determinants were assessed using Kaplan-Meier curves and binary logistic regression.ResultsSixty-six patients (42 males [63.6%]; median age 61.2 years; interquartile range [IQR] 45.9–71.9) presented an acute (n = 38; 57.6%) or chronic (n = 28; 42.4%) native MSSA arthritis (n = 15; 22.7%), osteomyelitis (n = 19; 28.8%) or spondylodiscitis (n = 32; 48.5%), considered as “difficult-to-treat” in 61 cases (92.4%). All received a prolonged (27.1 weeks; IQR, 16.9–36.1) combined antimicrobial therapy, after surgical management in 37 cases (56.1%). Sixteen treatment failures (24.2%) were observed during a median follow-up period of 63.3 weeks (IQR, 44.7–103.1), including 13 persisting infections, 1 relapse after treatment disruption, and 2 super-infections. Independent determinants of treatment failure were the existence of a sinus tract (odds ratio [OR], 5.300; 95% confidence interval [CI], 1.166–24.103) and a prolonged delay to infectious disease specialist referral (OR, 1.134; 95% CI 1.013–1.271).ConclusionsThe important treatment failure rate pinpointed the difficulty of cure encountered in complicated native MSSA BJI. An early infectious disease specialist referral is essential, especially in debilitated patients or in presence of sinus tract.Electronic supplementary materialThe online version of this article (doi:10.1186/1471-2334-14-443) contains supplementary material, which is available to authorized users.

Highlights

  • Methicillin-susceptible Staphylococcus aureus (MSSA) native bone and joint infection (BJI) constitutes the more frequent clinical entity of Bone and joint infections (BJIs), prognostic studies mostly focused on methicillin-resistant S. aureus prosthetic joint infection

  • Risk factors for treatment failure have poorly been studied. We addressed this question in a retrospective cohort study

  • All patients with native methicillin-susceptible Staphylococcus aureus (MSSA) BJI were enrolled in a monocentric retrospective cohort study (2001–2011) in the reference center for the management of complex BJI of the Lyon University Hospitals, France

Read more

Summary

Introduction

Methicillin-susceptible Staphylococcus aureus (MSSA) native bone and joint infection (BJI) constitutes the more frequent clinical entity of BJI, prognostic studies mostly focused on methicillin-resistant S. aureus prosthetic joint infection. We aimed to assess the determinants of native MSSA BJI outcomes. Bone and joint infections (BJIs) constitute difficult-totreat clinical entities, known to be associated to significant morbidity and mortality rates. Most of the current literature on BJI concerns orthopaedic device infections and/or methicillin-resistant Staphylococcus aureus (MRSA). Native infections represent the most frequent poorly been studied. We addressed this question in a retrospective cohort study

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call